Importantly, as high as 79.5% of the ESCC patients were with the ALDH2*2 genotype and had enriched ALDH2 associated Catalogue of Somatic Mutations in Cancer (COSMIC) mutational Signature 16 (i.e., increased T>C transitions) [80]. The gene discussed is ALDH2; the disease is esophageal squamous cell carcinoma.